RNACNasdaq United States
Market cap
$260.026 M
$8.85 +1.03%
Close of 7 Aug 2026
Revenue
$2.80M
#3399 by revenue
Earnings
-$130.3M
Loss-making
Shares outstanding
30,255,352
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cartesian Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.